Publication: Corrigendum: The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases (Frontiers in Immunology, (2024), 15, (1439413), 10.3389/fimmu.2024.1439413)
dc.contributor.author | Reste, Mariana (59397880700) | |
dc.contributor.author | Ajazi, Kristi (59397979800) | |
dc.contributor.author | Sayi-Yazgan, Ayca (57196466035) | |
dc.contributor.author | Jankovic, Radmila (36875127400) | |
dc.contributor.author | Bufan, Biljana (9533949300) | |
dc.contributor.author | Brandau, Sven (7003624762) | |
dc.contributor.author | Bækkevold, Espen S. (6602446295) | |
dc.contributor.author | Petitprez, Florent (57191611468) | |
dc.contributor.author | Lindstedt, Malin (6603560345) | |
dc.contributor.author | Adema, Gosse J. (7005155455) | |
dc.contributor.author | Almeida, Catarina R. (9637533600) | |
dc.date.accessioned | 2025-07-02T11:53:59Z | |
dc.date.available | 2025-07-02T11:53:59Z | |
dc.date.issued | 2025 | |
dc.description.abstract | In the published article, there was an error in the Funding statement. The section originally stated that “COST is supported by the EU Framework Program Horizon 2020”, while it should refer to “Horizon Europe”. The correct Funding statement appears below. “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was developed within the scope of projects with references UIDB/04501/2020 and https://doi.org/10.54499/UIDB/04501/2020, UIDP/04501/2020 and https://doi.org/10.54499/UIDP/04501/2020, 2022.03217.PTDC and DOI 10.54499/2022.03217.PTDC, financially supported by national funds (OE), through FCT - Fundação para a Ciência e Tecnologia, I.P./MCTES. This work was also supported by the World Scleroderma Foundation and Edit Busch Stiftung (MAPFib). This work has been supported by Ministry of Science, Technological Development and Innovation, Republic of Serbia through Grant Agreement with University of Belgrade, Faculty of Medicine No: 451-03-66/2024-03/200110. This work was funded by the Ministry of Science, Technological Development and Innovation, Republic of Serbia through Grant Agreement with University of Belgrade-Faculty of Pharmacy No: 451-03-47/2023-01/200161. This work was supported by the Wellcome Trust (225021/Z/22/Z). This work was supported by the Swedish Cancer Society (22 2221.Pj.01.H) and Mrs. Berta Kamprad’s Cancer Foundation (FBKS-2022-8-368). This work was supported by the Scientific and Technological Research Council of Turkey- TUBITAK (119S447 and 22AG077). This work was also supported by European Cooperation in Science and Technology (COST) Action CA20117 Mye-InfoBank (www.mye-infobank.eu); COST is supported by the EU Framework Program Horizon Europe.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Copyright © 2025 Reste, Ajazi, Sayi-Yazgan, Jankovic, Bufan, Brandau, Bækkevold, Petitprez, Lindstedt, Adema and Almeida. | |
dc.identifier.uri | https://doi.org/10.3389/fimmu.2025.1538818 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85218408215&doi=10.3389%2ffimmu.2025.1538818&partnerID=40&md5=fe2882ccb06e14ea97d11a89292f39c2 | |
dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/11512 | |
dc.subject | anti-tumor immunity | |
dc.subject | autoimmunity | |
dc.subject | dendritic cells (DC) | |
dc.subject | tertiary lymphoid organs (TLO) | |
dc.subject | tertiary lymphoid structures (TLS) | |
dc.title | Corrigendum: The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases (Frontiers in Immunology, (2024), 15, (1439413), 10.3389/fimmu.2024.1439413) | |
dspace.entity.type | Publication |